DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Transgenomic, Inc. (TBIO)
« Back to company indexTBIO Chatter Timeline
Stock Ticker for TBIO
Most Active Tweeters for TBIO
| User | Tweets |
|---|---|
| @MarketCurrents | 3 |
| @StockNewsWires | 3 |
| @Briefingcom | 3 |
| @HottestStockNow | 2 |
| @TickerReport | 2 |
Recent Tweets for TBIO
 |
@HottestStockNow $TBIO Reveals proposed public offering of $90M of its common stock #TranslateBio https://t.co/EnHSGF8BD0 September 17th 2019, 6:09pm |
 |
@Briefingcom $TBIO: Translate Bio announces commencement of $90 mln offering of common stock; all shares are being sold by the... https://t.co/jZwcW2zCIG September 17th 2019, 6:09pm |
 |
@StockNewsWires $TBIO: Translate Bio commences $90M stock offering; shares down 9 …: https://t.co/uA457ww4rk September 17th 2019, 4:09pm |
 |
@MarketCurrents $TBIO - Translate Bio commences $90M stock offering; shares down 9% after hours https://t.co/Bd4tW5Hh7g September 17th 2019, 4:09pm |
 |
@AndrewE_Dunn Translate Bio says they are raising $90M through public offering $TBIO https://t.co/vGWfLhz0MY September 17th 2019, 4:09pm |
 |
@Swan827 offering $TBIO 10.01 -0.98 (-8.92%) September 17th 2019, 4:09pm |
 |
@TraderTexMex $TBIO offering September 17th 2019, 4:09pm |
 |
@TickerReport Brokerages Anticipate Translate Bio Inc $TBIO to Post -$0.45 Earnings Per Share https://t.co/BrmmtEYL7x September 16th 2019, 8:09am |
 |
@ChartMill A Quick Ratio of 7.67 indicates that $TBIO has no problem at all paying its short term obligations.… https://t.co/i5AHkNW8nC September 16th 2019, 4:09am |
|
@TickerReport Translate Bio Inc $TBIO Short Interest Up 53.9% in August https://t.co/mINqH4U8bQ September 13th 2019, 10:09am |
 |
@newswelldone $TBIO: Moderna Wants the Body to Make Its Own Drugs. Analyst Sees Significant Progress.: https://t.co/NwfVOVU1xq September 13th 2019, 10:09am |
|
@Briefingcom $TBIO: Translate Bio enters into manufacturing agreement with Albany Molecular Research to support its mRNA... https://t.co/SBdCwmJLs2 September 12th 2019, 6:09pm |
 |
@Gambiste1 RT @MarketCurrents: $TBIO - Translate Bio inks mRNA manufacturing deal with AMR https://t.co/JxUkh0V9mU September 12th 2019, 5:09pm |
|
@StockNewsWires $TBIO: Translate Bio inks mRNA manufacturing deal with AMR: https://t.co/U4ZCW16rvx September 12th 2019, 5:09pm |
 |
@confcalltran Entry into a Material Definitive https://t.co/OaWV0MAVsU $TBIO September 12th 2019, 4:09pm |
|
@MarketCurrents $TBIO - Translate Bio inks mRNA manufacturing deal with AMR https://t.co/JxUkh0V9mU September 12th 2019, 4:09pm |
 |
@PersimmonTI $mRNA $TBIO +1 for mRNA this morning.. Antivirals/Vaccines are the low hanging fruit, but today’s early readout h… https://t.co/shrCbm2azh September 12th 2019, 8:09am |
 |
@dakotafinancial Translate Bio $TBIO Given a $17.00 Price Target at Citigroup https://t.co/ONdgne4DUa September 11th 2019, 10:09pm |
 |
@marketfolly Baupost Group increases Translate Bio stake https://t.co/vOQAzFl5YP $TBIO September 11th 2019, 2:09pm |
 |
@cmp_05 Baupost increased holding of $tbio https://t.co/v2afeq85yW September 11th 2019, 2:09pm |
 |
@JeffreyDubins RT @TranslateBio: Today, we announced several pipeline program updates. Read the full press release here: https://t.co/HvWuKqkm35 $TBIO htt… September 10th 2019, 6:09pm |
 |
@stocktilludrop $TBIO it appears that Translate LNP delivery ( 2.0 ) data cannot preform for their OTC deficiency indication. $ARCT… https://t.co/FDlHgh0jOT September 10th 2019, 9:09am |
|
@StockNewsWires $TBIO $MRNA: Translate Bio Drops Liver- Disease Program. The Stock Is Falling.: https://t.co/RQvLnt1iF7 September 10th 2019, 9:09am |
 |
@OpenOutcrier $TBIO (-3.8% pre) Translate Bio bails on OTC deficiency candidate MRT5201 - SA https://t.co/SiC0JjFqGO September 10th 2019, 8:09am |
 |
@newsfilterio $TBIO Seeking Alpha: In a pipeline update, Translate Bio announces that it will prioritize its pulmonary disease p… https://t.co/TbaPpejtLv September 10th 2019, 12:09am |
 |
@nataliamrkt $TBIO what a nice way to say that the preclinical studies of MRT5201 did not work?"today announced that it is prior… https://t.co/B05JKjYM5R September 9th 2019, 7:09pm |
|
@HottestStockNow $TBIO to discontinue development of MRT5201, a liver-targeted treatment for ornithine transcarbamylase deficiency… https://t.co/9ro5fRZljP September 9th 2019, 6:09pm |
|
@Briefingcom $TBIO: Translate Bio provides pipeline update; to discontinue development of MRT5201 https://t.co/27MejblXPI September 9th 2019, 6:09pm |
 |
@NewsToDesk $TBIO: Translate Bio bails on OTC deficiency candidate MRT5201: https://t.co/otx2RoB3s9 September 9th 2019, 5:09pm |
|
@biostockinfo RT @TraderTexMex: $TBIO Discontinuing development of MRT5201, a liver-targeted treatment for ornithine transcarbamylase (OTC) deficiency September 9th 2019, 4:09pm |
|
@confcalltran Seth A. Klarman just provided an update on share ownership of Transgenomic Inc. https://t.co/W8ySHrsCvU $TBIO September 9th 2019, 4:09pm |
|
@MarketCurrents $TBIO - Translate Bio bails on OTC deficiency candidate MRT5201 https://t.co/W0D4VfkBal September 9th 2019, 4:09pm |
 |
@Mykalt45 RT @MSollender: $TBIO Prioritizing and expanding pulmonary disease programs based on early positive cystic fibrosis (CF) data for MRT5005… September 9th 2019, 4:09pm |
 |
@MSollender $TBIO Prioritizing and expanding pulmonary disease programs based on early positive cystic fibrosis (CF) data for M… https://t.co/OONRd2mTDI September 9th 2019, 4:09pm |
 |
@Ultra_Calls $TBIO Discontinuing development of MRT5201, a liver-targeted treatment for ornithine transcarbamylase (OTC) deficiency September 9th 2019, 4:09pm |
 |
@Stock_News_Now $TBIO: New SEC Filing for TBIO: Form 10-Q (No. 0001558370-19-007876): https://t.co/JpggWjIGwY August 9th 2019, 3:08pm |
 |
@SeekingAlpha $TBIO - Translate Bio (TBIO) Investor Presentation - Slideshow https://t.co/jiCSKRCnj5 August 8th 2019, 6:08pm |
|
@TickerReport Q3 2019 EPS Estimates for Translate Bio Inc $TBIO Lowered by Analyst https://t.co/PvhX9itwSZ August 7th 2019, 1:08am |
|
@TickerReport Jefferies Financial Group Weighs in on Translate Bio Inc’s Q3 2019 Earnings $TBIO https://t.co/2hbqEMEqKk August 7th 2019, 1:08am |
 |
@dailypoliticaln Jefferies Financial Group Weighs in on Translate Bio Inc’s Q3 2019 Earnings $TBIO https://t.co/rhmD0BQDk7 August 7th 2019, 1:08am |
|
@dakotafinancial Translate Bio Inc $TBIO Expected to Post Quarterly Sales of $1.77 Million https://t.co/tL5xrxfK2g August 5th 2019, 7:08pm |
 |
@dispatchtribune Translate Bio $TBIO Given Buy Rating at HC Wainwright https://t.co/9aAozkHtnw August 2nd 2019, 8:08pm |
 |
@Gupta_Calling $TBIO TP $20 Jefferies Starts Translate Bio (TBIO) at Buy https://t.co/b5LIeBmrhL August 2nd 2019, 9:08am |
 |
@CSIMarket $TBIO #stock #StockMarket #TranslateBio issued on https://t.co/savSNU1XbB Company lost money at $-0.57 per share i… https://t.co/cOPwkTOmPy August 2nd 2019, 3:08am |
|
@dakotafinancial Translate Bio $TBIO Announces Quarterly Earnings Results https://t.co/pon0tU6TlH August 1st 2019, 8:08pm |
 |
@WeekHerald Translate Bio $TBIO Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS https://t.co/n82VheUXut August 1st 2019, 4:08pm |
 |
@ThisLincolnian Translate Bio $TBIO Announces Quarterly Earnings Results https://t.co/bcrL9Nwxpa August 1st 2019, 4:08pm |
|
@ThisLincolnian Translate Bio $TBIO Given Buy Rating at HC Wainwright https://t.co/5J9dOfwYq6 August 1st 2019, 10:08am |
|
@WeekHerald Translate Bio $TBIO Given Buy Rating at HC Wainwright https://t.co/DWkyEldoZD August 1st 2019, 10:08am |
 |
@endpts Atlantic Healthcare's drug fails late-stage test; Translate Bio breaks out early #CF data https://t.co/HewPeBPlh6 $TBIO August 1st 2019, 2:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.